Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Equinor ASA: Buy-back of shares to share programmes for employees
-
Intention to transition to the Main Market of the London Stock Exchange and Voluntary Delisting from the TSX Venture Exchange
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
Bavarian Nordic Receives USD 22.5 Million Contract for its Mpox and Smallpox Vaccine from the Government of Canada
-
Baltic Horizon will hold an Investor Conference Webinar to introduce the results for Q4 2025 and New Units Offering 2026
-
Transaction in Own Shares
-
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
-
Year-end Report 2025
-
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
-
FLSmidth 2025 Annual Report: Solid performance provides strong foundation for the next phase, focused on accelerating growth
-
Fiverr Announces Fourth Quarter and Full Year 2025 Results
-
Start of Day Message
-
IMCD reports EBITA of EUR 498 million in 2025
-
Hepsor AS consolidated unaudited interim report for Q4 2025 and twelve months
-
Defeating the "Cold Chain" Barrier: Bio Usawa and Nanoly Bioscience Announce Strategic $500 Million Licensing Agreement for Breakthrough DynaShield™ Technology
-
FLSmidth: Transactions under share buy-back programme
-
Getty Realty Corp. Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
-
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
-
Metaculus Launches FutureEval to Track AI Forecasting Accuracy
-
BellaVita Luxury Introduces Bellavita Water-Based Hair & Body Mist
-
BellaVita Luxury Introduces Bellavita Water-Based Hair & Body Mist
-
Humanoid Global Announces Marketing Services
-
Xsolis Announces the Appointment of Vic Pierni as Chief Financial Officer
-
B.C. budget supports growth but falls short for many workers, says United Steelworkers
-
Purpose Investments Inc. Announces February 2026 Distributions
-
CECO Environmental to Release Fourth Quarter Earnings and Host Conference Call on February 24
-
Novo Resources Releases Updated Corporate Presentation
-
-
SHARC Energy Announces $2.0M Convertible Debenture Financing With 25% Greenshoe
-
ISTO, Inc. Elects New Board Member
-
Traction Uranium Announces Proposed Share Consolidation
-
B.C. Budget Fails to Stabilise Fiscal Trajectory
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Argo Corporation Announces Investment And Lock-Up Agreements By Co-Founders
-
b1BANK partners with Covecta to deploy agentic AI
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Canfor announces asset write-down and impairment charge
-
Future Mineral Announces AGM Results
-
Canfor Pulp announces asset write-down and impairment charge
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Constellation Software Inc. Announces Conference Call to Discuss Fourth Quarter Results

